| Literature DB >> 26178019 |
Kemal Yuksel1, Ugur Celik2,3, Cengiz Alagoz4, Huseyin Dundar5, Burcu Celik1, Ahmet Taylan Yazıcı6.
Abstract
BACKGROUND: To evaluate the morpho-functional outcomes and safety of transconjuctival 23-gauge pars plana vitrectomy(PPV) for removal of intraocular foreign bodies (IOFBs).Entities:
Mesh:
Year: 2015 PMID: 26178019 PMCID: PMC4504162 DOI: 10.1186/s12886-015-0067-2
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Demographical data of patients
| Demographics and clinical features ( | ||
|---|---|---|
| Age | Years Mean ± SD, (Range) | 34.2 ± 10.9 |
| Gender | Female | 9 |
| Male | 27 | |
| Eye | Right | 54.1 % |
| Left | 45.9 % | |
| Intervala | Days Mean ± SD, (Range) | 14.2 ± 19,4(1–120) |
| Follow-up | Months Mean ± SD, (Range) | 9.4 ± 6.4(2–27) |
aThe time between the injury to surgery
Characteristics of Intraocular Foreign Bodies
| Number (%) | |
|---|---|
| IOFB entrance | |
| Corneal | 26 (%72,2) |
| Scleral | 10 (%28,8) |
| Corneascleral | 0 (%0.0) |
| IOFB location | |
| Vitreus | 20 (%55,6) |
| Retina | 16 (%44,4) |
| IOFB type | |
| Metallic | 28 (%78,8) |
| Stone | 8 (%22,2) |
Distrubition of preoperative and final visual acuities
| Preoperative, n (%) | Final visit, n (%) |
| |
|---|---|---|---|
| HM* or less | 10 (%27,8) | 4 (%11,1) | >0.05 |
| CF**- < = 0.1 | 6 (%16,6) | 10 (%27,8) | >0.05 |
| >0.1- < = 0.3 | 6 (%16,6) | 2 (%5,5) | >0.05 |
| >0.3 | 16 (%44,4) | 20 (%55,6) | >0.05 |
HM hand movement; CF finger count
Baseline and final visit BCVA of patients based on IOFB characteristics
| Baseline BCVAa | Final Visit BCVAa | P values | |
|---|---|---|---|
| IOFB entrance | |||
| Corneal | 1,22 | 0,80 | 0,029 |
| Scleral | 2,02 | 0,74 | 0,443 |
| P1 | 0,568 | 0,183 | |
| IOFB type | |||
| Metallic | 1,18 | 0,60 | 0,022 |
| Stone | 1,87 | 1,31 | 0,082 |
| P1 | 0,127 | 0,100 | |
| IOFB Location | |||
| Retina | 1,42 | 0,89 | 0,070 |
| Vitreus | 1,19 | 0,55 | 0,871 |
| P1 | 0,077 | 0,470 |
aLogMAR BCVA values. P values <0.05 was considered as significant
Surgical procedures
| n (%) | |
|---|---|
| Surgical | |
| 23G PPV + IOFB removal | 17 (47,2 %) |
| 23G PPV + IOFB removal + PHACO + IOL imp | 17 (47.2 %) |
| 23G PPV + IOFB removal + IOL imp | 2 (5,5 %) |
| Intraocular tamponades | |
| No | 14 (38.8 %) |
| Silicone oil | 8 (22,6 %) |
| Gas (C3F8/SF6) | 14 (38,8 %) |